News & Updates
Filter by Specialty:
Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC
In the third-line treatment of patients with refractory RAS wild-type metastatic colorectal cancer (MCRC), use of panitumumab plus the standard-of-care trifluridine-tipiracil appears to prolong progression-free survival (PFS) when compared with trifluridine-tipiracil alone, according to data from a phase II study.
Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC
21 May 2023
Takotsubo syndrome tied to impaired LV contractility, shortened systolic period
Patients with Takotsubo syndrome (TTS), a reversible form of heart failure with incompletely understood pathophysiology, may exhibit reduced cardiac contractility, shortened systolic period, inefficient energetics, and prolonged active relaxation but unaffected diastolic passive stiffness, a study has shown.
Takotsubo syndrome tied to impaired LV contractility, shortened systolic period
21 May 2023
Herbal combination works in treatment of active ulcerative colitis
The herbal combination of curcumin plus QingDai (CurQD) appears beneficial to patients with active ulcerative colitis (UC), with a recent study showing that the combination induced clinical and biomarker remission.
Herbal combination works in treatment of active ulcerative colitis
20 May 2023
In-utero exposure to poor air quality a risk factor for childhood ADHD
Children born to mothers who were exposed to polluted air while pregnant are at increased risk of childhood attention-deficit hyperactivity disorder (ADHD), according to a study presented at PAS 2023.
In-utero exposure to poor air quality a risk factor for childhood ADHD
20 May 2023
Broad-spectrum antibiotic exposure ups risk of IBD
Exposure to broad-spectrum antibiotics may put individuals at risk of developing inflammatory bowel disease (IBD), such that the greater the dose, the higher the risk, as shown in a study.
